These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1551206

  • 1. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy.
    Rudd MA, George D, Johnstone MT, Moore RT, Collins L, Rabbani LE, Loscalzo J.
    Circ Res; 1992 Apr; 70(4):829-34. PubMed ID: 1551206
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 3. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ, Prager NA, Sobel BE, Abendschein DR.
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [Abstract] [Full Text] [Related]

  • 4. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.
    Yao SK, McNatt J, Anderson HV, Eidt J, Cui KX, Golino P, Glas-Greenwalt P, Maraganore J, Buja LM, Willerson JT.
    Am J Physiol; 1992 Feb; 262(2 Pt 2):H374-9. PubMed ID: 1539695
    [Abstract] [Full Text] [Related]

  • 5. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets.
    Prager NA, Torr-Brown SR, Sobel BE, Abendschein DR.
    J Am Coll Cardiol; 1993 Jul; 22(1):296-301. PubMed ID: 8509554
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR, Sobel BE.
    Thromb Res; 1993 Dec 01; 72(5):413-21. PubMed ID: 8303684
    [Abstract] [Full Text] [Related]

  • 7. Affects of hirudin and heparin on the binding of new fibrin to the thrombus in t-PA treated rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1991 Nov 01; 66(5):592-7. PubMed ID: 1839474
    [Abstract] [Full Text] [Related]

  • 8. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct 01; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.
    Mirshahi M, Soria J, Soria C, Faivre R, Lu H, Courtney M, Roitsch C, Tripier D, Caen JP.
    Blood; 1989 Aug 15; 74(3):1025-30. PubMed ID: 2502207
    [Abstract] [Full Text] [Related]

  • 10. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK, Ober JC, Ferguson JJ, Anderson HV, Maraganore J, Buja LM, Willerson JT.
    Circulation; 1992 Dec 15; 86(6):1993-9. PubMed ID: 1451271
    [Abstract] [Full Text] [Related]

  • 11. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS, Zoldhelyi P, Webster MW, Heras M, Grill DE, Holmes DR, Fuster V, Chesebro JH.
    Circulation; 1996 Feb 15; 93(4):792-9. PubMed ID: 8641009
    [Abstract] [Full Text] [Related]

  • 12. The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke.
    Bednar MM, Quilley J, Russell SR, Fuller SP, Booth C, Howard D, Gross CE.
    Neurosurgery; 1996 Aug 15; 39(2):352-9. PubMed ID: 8832673
    [Abstract] [Full Text] [Related]

  • 13. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI, Leslie B, Hudoba M.
    Circulation; 1998 Feb 17; 97(6):544-52. PubMed ID: 9494024
    [Abstract] [Full Text] [Related]

  • 14. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E, Lunven C, Gauffeny C, Roome NO, Berry CN.
    Thromb Haemost; 1998 Nov 17; 80(5):840-4. PubMed ID: 9843181
    [Abstract] [Full Text] [Related]

  • 15. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
    Meyer BJ, Badimon JJ, Chesebro JH, Fallon JT, Fuster V, Badimon L.
    Circulation; 1998 Feb 24; 97(7):681-5. PubMed ID: 9495304
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of adjunctive intrathrombic heparin with pulse spray thrombolysis in rabbit inferior vena cava thrombosis.
    Valji K, Bookstein JJ.
    Invest Radiol; 1992 Nov 24; 27(11):912-7. PubMed ID: 1464509
    [Abstract] [Full Text] [Related]

  • 17. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G, Alloatti G, Mariano F, Lupia E, Lucchina PG, Musso E, Emanuelli G, Camussi G.
    Circ Res; 1993 Mar 24; 72(3):658-70. PubMed ID: 8381725
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of hirudin on tissue plasminogen activator induced clot lysis.
    Electricwala A, Atkinson T.
    Blood Coagul Fibrinolysis; 1990 Aug 24; 1(3):267-71. PubMed ID: 2129413
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.